Ethyl 2-chloro-4-methoxy-3-oxobutanoate → Ethyl 2-(4-aminopiperidin-1-yl)-4-(methoxymethyl)-1,3-thiazole-5-carboxylate hydrochloride
反応式
[NH2:1][C:2]([N:4]1[CH2:9][CH2:8][CH:7]([NH:10]C(=O)OC(C)(C)C)[CH2:6][CH2:5]1)=[S:3].[Cl:18][CH:19]([C:25](=O)[CH2:26][O:27][CH3:28])[C:20]([O:22][CH2:23][CH3:24])=[O:21]>>[ClH:18].[NH2:10][CH:7]1[CH2:6][CH2:5][N:4]([C:2]2[S:3][C:19]([C:20]([O:22][CH2:23][CH3:24])=[O:21])=[C:25]([CH2:26][O:27][CH3:28])[N:1]=2)[CH2:9][CH2:8]1参加物
3
実験手順
The title compound was prepared in a manner analogous to Intermediate 126 starting from tert-butyl [1-(aminocarbonothioyl)piperidin-4-yl]carbamate (Intermediate 125) and ethyl 2-chloro-4-methoxy-3-oxobutanoate (Intermediate 6).
出典と根拠
- ORDレコード
- ord-dabb03090afb4cf781578ff95f3cb7b9
- 出典データセット
- uspto-grants-2010_05
- 特許番号
- US07709503B2
反応ノート
読み込み中…